NIH

Heart illustration
August 20, 2014

Study finds coronary arteries hold heart-regenerating cells

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered.

By Leigh MacMillan
August 20, 2014

Enzyme holds the door for influenza

Compounds developed at Vanderbilt University may offer a new way to block influenza infection.

By VUMC News and Communications
August 19, 2014

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

By Leigh MacMillan
August 15, 2014

Weight regain after gastric bypass

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the “hunger hormone” ghrelin might indicate who is susceptible to weight regain.

By Leigh MacMillan
August 14, 2014

Penson to chair NIH health services research study section

Vanderbilt’s David Penson, M.D., MPH, director of the Center for Surgical Quality and Outcomes Research, has been named to serve as chair of the Health Services Organization and Delivery Study Section in the Center for Scientific Review (CSR) of the National Institutes of Health. He will serve a two-year term.

By VUMC News and Communications
August 14, 2014

Growth factor blockade targets breast tumors

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.

By VUMC News and Communications
August 7, 2014

Novel treatment strengthens bones in genetic disease

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.
By Leigh MacMillan
August 6, 2014

Low selenium and lung cancer

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.
By Yan Su
August 5, 2014

Drug discovery clues in network map

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.
By Bill Snyder
August 1, 2014

Anti-inflammatory protein “rheostat” sheds light on leaky blood vessels

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.
By Emily Poulin
July 31, 2014

New target for breast cancer therapy

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics.
By Leigh MacMillan
July 23, 2014

Natural killer cells don’t clear HMPV

Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.
By Leigh MacMillan
July 21, 2014

Reversing stress-induced anxiety

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders.
By Leigh MacMillan